Daniel Housman is listed as an executive officer and director on 1 SEC Form D filing by 1 issuer in May 2025: COURAGE THERAPEUTICS, INC. (Newton, MA — biotechnology — 2025; $4.51M reported sold to 14 investors).
What this means One deal on file with the SEC, filed May 2025. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Bruce Leutcher (1 shared filing), Isaac Barchas (1 shared filing) and Roger Cone (1 shared filing).
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Daniel. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 1 bankruptcy case matching the name listed in Key records below.
What this means 1 record came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 1 public filing for Daniel Housman and found 2 differences: Form D filed 22 days after the first sale; No amendment in the last 12 months on an offering that may still be open.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.